Abstract On March 11, 2020, the World Health Organization declared Coronavirus Disease
2019 (COVID-19) a pandemic. Till now, it affected 452.4 million (Spain, 11.18 million) …

Idiopathic pulmonary fibrosis (IPF) is considered the paradigmatic example of chronic
progressive fibrosing disease; IPF does not result from a primary immunopathogenic …

Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although it has been a fatal …

Objectives: Data on COVID-19 in patients with interstitial lung disease are scarce and
whether SARS-CoV-2 may trigger interstitial lung disease progression remains unknown …

SARS-CoV2 infection has a poor prognosis in patients affected of idiopathic pulmonary
fibrosis (IPF). Autoantibodies (auto-Abs) neutralizing type I interferons (IFNs) are found in the …

Background Previous studies have consistently reported a decrease in hospital admissions
for respiratory diseases during the coronavirus disease 2019 (COVID-19) pandemic …

We present a case of 79-year-old female with rheumatoid arthritis-associated interstitial lung
disease (RA-ILD) developed an acute exacerbation (AE) triggered by coronavirus disease …

An 82-year-old man diagnosed with interstitial lung disease through computed tomography
(CT) 1 year prior received a bivalent (tozinameran and famtozinameran) mRNA COVID-19 …

Die SARS-CoV-2-Pandemie hat in erheblichem Umfang die Diagnostik und Therapie
interstitieller Lungenerkrankungen (ILD) beeinflusst. Insbesondere in der Frühphase der …

Les interactions entre pneumopathies interstitielles diffuses (PID) et infections respiratoires
sont complexes. Cette session a été l'occasion d'une mise au point sur les liens entre …